Breakthrough Therapies - HER2 with Dr. Bob T. Li


About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers.  To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu  and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.

Stephen Liu, MD
Stephen Liu


Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Dr. Bob Li
Bob T. Li


Medical Oncologist Thoracic Oncology and Early Drug Development Service Chief Scientific Officer; Direct Co-Director, Thoracic Liquid Biopsy Program Physician Ambassador
Memorial Sloan Kettering Cancer Center
China and Asia-Pacific Bobst International Center

Other Podcast